Open Nav

Please submit your session questions in advance at

ImmunSYS, Inc.

  • Joseph Gerardi, ImmunSYS, Inc.

ImmunSYS is a clinical stage biopharmaceutical company focused on the development of innovative cancer immunotherapy products to improve the lives of patients with late-stage metastatic cancers. Immunotherapy, also called biologic therapy, is a type of cancer treatment that boosts the body's natural defenses to fight cancer. It uses substances made by the body or in a laboratory to improve or restore immune system function. Immunotherapy may work by:

*Stopping or slowing the growth of cancer cells

*Stopping cancer from spreading to other parts of the body

*Helping the immune system work better at destroying cancer cells.

Our platform technology, YourVaccx™ utilizes a novel combination of the proprietary ANTIGENerator™ energy delivery device system, a proprietary branded formulation of immunotherapeutic drugs, and a proprietary procedure developed by the focal prostate cancer therapy pioneer Gary Onik, M.D.

  • Date:Tuesday, February 12
  • Time:1:15 PM - 1:30 PM
  • Room:Chelsea
  • Location:7th Floor
  • Session Type:Company Presentation
  • Company Presentation - Presentation Type:Privately Funded Company
  • Submission ID:23549
  • Goal for Presentation:Find Strategic Partners and Investors
  • Company
  • Company HQ City:Fort Lauderdale
  • Company HQ State:Florida
  • Company HQ Country:United States
  • Total Amount Raised to Date, in All Rounds:$13 Million
  • Size of Last Investment Round:$6 Million
  • Previous and Current Investors:Private
  • CEO/Top Company Official:Eamonn P. Hobbs Chairman & CEO
  • Year Founded:2018
  • Main Therapeutic Focus:Immunology
  • Lead Product in Development:YourVacxx Therapy
  • Development Phase of Primary Product:Phase I
  • Number Of Unlicensed Products (For Which You Are Seeking Partners):3 see below
  • Additional Information/Comments:PD-1 CTLA-4 GM-CSF
Joseph Gerardi
ImmunSYS, Inc.